Ollivier Legrand

Ontology type: schema:Person     

Person Info





Publications in SciGraph latest 50 shown

  • 2021-09-03 Outcome of allogeneic hematopoietic stem cell transplant recipients admitted to the intensive care unit with a focus on haploidentical graft and sequential conditioning regimen: results of a retrospective study in ANNALS OF HEMATOLOGY
  • 2021-05-25 Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients in NATURE COMMUNICATIONS
  • 2021-02-09 Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia in BONE MARROW TRANSPLANTATION
  • 2020-05-06 COVID-19 outcomes in patients with hematologic disease in BONE MARROW TRANSPLANTATION
  • 2019-10-31 Thiotepa and antithymocyte globulin-based conditioning prior to haploidentical transplantation with posttransplant cyclophosphamide in high-risk hematological malignancies in BONE MARROW TRANSPLANTATION
  • 2019-09-25 Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia in BONE MARROW TRANSPLANTATION
  • 2017-08-04 Targeting primary acute myeloid leukemia with a new CXCR4 antagonist IgG1 antibody (PF-06747143) in SCIENTIFIC REPORTS
  • 2016-08-18 Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia in NATURE COMMUNICATIONS
  • 2016-03-01 Clonal history of a cord blood donor cell leukemia with prenatal somatic JAK2 V617F mutation in LEUKEMIA
  • 2014-07-14 Report of disseminated Mycobacterium haemophilum infection after double cord blood allo-SCT in BONE MARROW TRANSPLANTATION
  • 2011-04-26 Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia in INVESTIGATIONAL NEW DRUGS
  • 2011 Traitement des leucémies aiguës in THÉRAPEUTIQUE DU CANCER
  • 2009-06-23 P-gp activity is a critical resistance factor against AVE9633 and DM4 cytotoxicity in leukaemia cell lines, but not a major mechanism of chemoresistance in cells from acute myeloid leukaemia patients in BMC CANCER
  • 2008-04-24 Is BAL useful in patients with acute myeloid leukemia admitted in ICU for severe respiratory complications? in LEUKEMIA
  • 2008-02-13 Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML) in BMC CANCER
  • 2007-04-12 ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra? in LEUKEMIA
  • 2006-10-19 High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group in LEUKEMIA
  • 2006-07-18 A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia in BRITISH JOURNAL OF CANCER
  • 2006-07-13 Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study in LEUKEMIA
  • 2004-04-29 Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1 in LEUKEMIA
  • 2004-02-05 Incidence and prognostic value of respiratory events in acute leukemia in LEUKEMIA
  • 2002-11-14 Drug Resistance in Acute Leukemias in TREATMENT OF ACUTE LEUKEMIAS
  • 1999-04-01 Role of MRP1 in multidrug resistance in acute myeloid leukemia in LEUKEMIA
  • 1999-02 Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients in SUPPORTIVE CARE IN CANCER
  • 1999 MDR1/P-GP Expression as A Prognostic Factor in Acute Leukemias in DRUG RESISTANCE IN LEUKEMIA AND LYMPHOMA III
  • 1999 Both Pgp and MRP1 Activities Using Calcein-AM Contribute to Drug Resistance in AML in DRUG RESISTANCE IN LEUKEMIA AND LYMPHOMA III
  • 1998-08-01 Both P-gp and MRP contribute to drug resistance in AML in LEUKEMIA
  • 1998 Management of Fever in Adult Hematological Neutropenic Patients: Comparison of Tazocillin + Aminoside versus Ceftazidime + Aminoside in 466 Febrile Episodes in ACUTE LEUKEMIAS VII
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.412370.3", 
              "type": "Organization"
            "isCurrent": true, 
            "type": "OrganizationRole"
            "id": "http://www.grid.ac/institutes/grid.465261.2", 
            "type": "Organization"
            "id": "http://www.grid.ac/institutes/grid.417925.c", 
            "type": "Organization"
            "id": "http://www.grid.ac/institutes/grid.411394.a", 
            "type": "Organization"
            "id": "http://www.grid.ac/institutes/grid.412180.e", 
            "type": "Organization"
            "id": "http://www.grid.ac/institutes/grid.7429.8", 
            "type": "Organization"
            "id": "http://www.grid.ac/institutes/grid.462844.8", 
            "type": "Organization"
        "familyName": "Legrand", 
        "givenName": "Ollivier", 
        "id": "sg:person.0752753564.08", 
        "sameAs": [
        "sdDataset": "persons", 
        "sdDatePublished": "2022-05-20T08:04", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/person/person_697.jsonl", 
        "type": "Person"

    Download the RDF metadata as:  json-ld nt turtle xml License info


    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0752753564.08'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0752753564.08'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0752753564.08'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0752753564.08'


    This table displays all metadata directly associated to this object as RDF triples.

    28 TRIPLES      10 PREDICATES      17 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0752753564.08 schema:affiliation Nd93b629fa1914118b5975013b8f7b182
    2 grid-institutes:grid.411394.a
    3 grid-institutes:grid.412180.e
    4 grid-institutes:grid.417925.c
    5 grid-institutes:grid.462844.8
    6 grid-institutes:grid.465261.2
    7 grid-institutes:grid.7429.8
    8 schema:familyName Legrand
    9 schema:givenName Ollivier
    10 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752753564.08
    11 schema:sdDatePublished 2022-05-20T08:04
    12 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    13 schema:sdPublisher N3f62bc90be834e4aa298bc26ef50d25b
    14 sgo:license sg:explorer/license/
    15 sgo:sdDataset persons
    16 rdf:type schema:Person
    17 N3f62bc90be834e4aa298bc26ef50d25b schema:name Springer Nature - SN SciGraph project
    18 rdf:type schema:Organization
    19 Nd93b629fa1914118b5975013b8f7b182 schema:affiliation grid-institutes:grid.412370.3
    20 sgo:isCurrent true
    21 rdf:type schema:OrganizationRole
    22 grid-institutes:grid.411394.a schema:Organization
    23 grid-institutes:grid.412180.e schema:Organization
    24 grid-institutes:grid.412370.3 schema:Organization
    25 grid-institutes:grid.417925.c schema:Organization
    26 grid-institutes:grid.462844.8 schema:Organization
    27 grid-institutes:grid.465261.2 schema:Organization
    28 grid-institutes:grid.7429.8 schema:Organization

    Preview window. Press ESC to close (or click here)